Valérie Vanhoorne

Prof. Dr. Valérie Vanhoorne

Universiteit Gent, Ghent, Belgium
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
GVG. Verstraete
G. Verstraete
ASAseel Samaro
Aseel Samaro
WGW. Grymonpré
W. Grymonpré
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne
BSB. Van Snick
B. Van Snick
CVChris Vervaet
Chris Vervaet

1 April 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne
CVChris Vervaet
Chris Vervaet

27 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AVArnau Vidal
Arnau Vidal
LCLiesel Claeys
Liesel Claeys
MMMarcel Mengelers
Marcel Mengelers
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne
CVChris Vervaet
Chris Vervaet
MBMarthe De Boevre
Marthe De Boevre
For the first time, a comprehensive human intervention study was conducted to unravel the urinary excretion profile and metabolism of the fungal metabolite deoxynivalenol (DON) and its modified form deoxynivalenol-3-glucoside (DON-3-glucoside). Twenty volunteers were restricted in consuming cereals and cereal-based foods for 4 days. At day 3, a single bolus of 1 µg/kg body weight of DON and a single bolus of 1 µg/kg body weight of DON-3-glucoside after a washing-out period of two months was administered, and a 24-h urine collection was performed. The urine was analysed for DON, DON-3-glucoside, 3-ADON, 15-ADON, deepoxy-deoxynivalenol (DOM-1), deoxynivalenol-3-glucuronide (DON-3-glucuronide) and deoxynivalenol-15-glucuronide (DON-15-glucuronide). The urinary biomarker-analysis revealed that DON and DON-3-glucoside were rapidly absorbed, distributed, metabolized and excreted. Sixty-four % of the administered DON and 58% of DON-3-glucoside was recovered in the urine collected within 24 h. DON-15-glucuronide was the most prominent urinary biomarker followed by free DON and DON-3-glucuronide. Moreover, correlations among the presence of DON-15-glucuronide and DON-3-glucuronide were observed (within 24 hours (r = 0.61)). The DOM-1 detected in the urine was higher after the DON-3-glucoside administration. The obtained results are imperative to construct a standardized method to estimate DON-intake by means of urinary biomarkers.

1 July 2014 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Ashish KumarAshish Kumar
Ashish Kumar
JVJurgen Vercruysse
Jurgen Vercruysse
MTMaunu Toiviainen
Maunu Toiviainen
PPPierre-Emmanuel Panouillot
Pierre-Emmanuel Panouillot
MJMikko Juuti
Mikko Juuti
Ingmar NopensIngmar Nopens
Ingmar Nopens

1 October 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
BSBernd Van Snick
Bernd Van Snick
JDJens Dhondt
Jens Dhondt
KPKenny Pandelaere
Kenny Pandelaere
JBJohny Bertels
Johny Bertels
RMRoel Mertens
Roel Mertens
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne

1 August 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
BSB. Van Snick
B. Van Snick
JHJ. Holman
J. Holman
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne
Ashish KumarAshish Kumar
Ashish Kumar
TBT. De Beer
T. De Beer
CVChris Vervaet
Chris Vervaet